Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 14, 2023

Study Completion Date

June 14, 2023

Conditions
Acute Ischemic Stroke
Interventions
OTHER

hUCB

"1. The cord blood need to be infusion within less than 10 days after the onset of stroke, and the cord blood mononuclear cells 200 million \~ 500 million will used.~2. 20% mannitol 200 ml iv for 30±10 min/q8h±2h will be administered twice after cord blood infusion ."

Trial Locations (1)

707

Hualien Tzu Chi Hospital, Hualien City

All Listed Sponsors
collaborator

Buddhist Tzu Chi General Hospital

OTHER

collaborator

StemCyte Taiwan Co., Ltd.

INDUSTRY

lead

China Medical University Hospital

OTHER

NCT02433509 - Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter